Suchergebnisse - "Shull, Austin Y"

PubPharm (23)

1

Nicotinic acetylcholine receptor CHRNA5 is overexpressed in head and neck squamous cell carcinoma patients with a recent tobacco smoking history

enthalten in: microPublication biology | 2024

von McGuinness, C. | White, S. | Gray, E. | +3

2

IL32 overexpression is driven by DNA hypomethylation and contributes to an extracellular matrix (ECM) remodeling phenotype in EpCAM‐/CD49f‐enriched breast cancer cells

enthalten in: The FASEB Journal | 2022

von Benson, E. | Wilson, M. | Gray, E. | +4

3

SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3

enthalten in: Journal of experimental & clinical cancer research : CR | 2021

von Teng, Y. | Loveless, R. | Benson, E. | +3

4

SHOX2 cooperates with STAT3 to promote breast cancer metastasis through the transcriptional activation of WASF3

enthalten in: Journal of experimental & clinical cancer research | 2021

von Teng, Y. | Loveless, R. | Benson, E. | +3

5

FGF19 amplification reveals an oncogenic dependency upon autocrine FGF19/FGFR4 signaling in head and neck squamous cell carcinoma

enthalten in: Oncogene | 2019

von Gao, L. | Lang, L. | Zhao, X. | +3

6

Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer

enthalten in: American journal of cancer research | 2019

von Shi, S. | Lee, E. | Lin, Y. | +12

7

Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression

enthalten in: Current cancer drug targets | 2019

von Lang, L. | Shull, A. | Teng, Y.

8

Interrupting the FGF19-FGFR4 Axis to Therapeutically Disrupt Cancer Progression

enthalten in: Current cancer drug targets | 2019

von Lang, L. | Shull, A. | Teng, Y.

9

Making way for suppressing the FGF19/FGFR4 axis in cancer

enthalten in: Future medicinal chemistry | 2018

von Prieto-Dominguez, N. | Shull, A. | Teng, Y.

10

'Et tu, inhibitor?' : the potential for HIV inhibitors to prime P-gp-mediated chemoresistance in cancer

enthalten in: Future science OA | 2018

von Shull, A. | Farrell, C.